Prenatal diagnosis and follow-up of a child with mosaic tetrasomy 9p without obvious abnormal clinical manifestations Authors: Lifang Zhang, Feiyan Qian, Weiping Chen, Jiaming Fan, Yan Zeng, Tingting Luo, Ming Che, Bin Yu, Tao Zhang Published: 2026 ABSTRACT AbstractIntroduction To report the prenatal diagnosis and follow-up of a fetus with mosaic tetrasomy 9p without obvious abnormal clinical manifestations.Case report A fetus diagnosed with mosaic T9p at Shaoxing Maternal and Child Health Hospital in February 2022 was selected as the study subject. The amniotic fluid karyotype was 47,XY,+i(9)(p10)[3]/46,XY[97]. CNV-seq revealed a 70.56 Mb copy number gain in 9p24.3q21.11 (mosaicism at 6%). After genetic counseling, the parents opted to continue the pregnancy. A 3.9 kg male fetus was delivered at full term with normal physical findings at birth. The baby was phenotypically normal and had normal psychomotor and language development at 3 years old, at our last postnatal follow-up. When the child was 3 years old, his physical measurement parameters (height: 97 cm; weight: 14 kg) and neurodevelopment milestones all met the age standards. His peripheral blood karyotype was 47,XY,+i(9)(p10)[10]/46,XY[90], with CNV-seq analysis indicating a 39.16 Mb copy number gain in the 9p24.3p13.1 region (mosaicism at 53%). This discrepancy with the amniotic fluid CNV-seq results was attributed to differences in segmentation algorithms or software. FISH detected T9p mosaicism in oral mucosa (11.2%) and urinary sediment cells (12.7%). A synthesis of data from karyotype analysis, CNV-seq, and FISH collectively substantiates the presence of an acquired alteration within the 9p region, while the evidence does not support the extension of this fragment across the centromere of chromosome 9 into the q arm.Conclusion The combined use of various methods may be capable of more accurately determining break-points and mosaic levels of T9p during prenatal diagnosis. This enriches the clinical spectrum of T9p mosaicism and provides a basis for prenatal diagnosis and genetic counseling of children with this type of chromosome variation.Keywords: Mosaicism, Tetrasomy 9p, Prenatal diagnosis, Phenotype, CNV-seq, FISH Introduction Tetrasomy 9p (T9p), a rare chromosomal syndrome, was initially documented in 1973 [6]. This condition causes chromosomal imbalance because of extrachromosomal material originating from two extra copies of the short (p) arm of chromosome 9 due to the formation of an isochromosome. T9p has been described in two forms: i(9p), where the two short arms are linked by a single centromeric region, and isodicentric 9p [idic(9p)] with the breakage and reunion in the long arm linking one active and one inactive centromere [1]. U-shaped exchange is a potential mechanism for the formation of isochromosomes. The mosaic phenotype of T9p has been reported in fetuses with various structural abnormalities, facial deformities, and delayed growth and development, as well as in adults with normal phenotypes [4, 8, 12, 13, 10, 7]. Most cases are recorded after birth, and prenatal diagnosis is rare. The severity of phenotypic variation and clinical features of T9p may be related to differences in mosaic and non-mosaic forms, level of mosaicism, extent of mosaicism in different tissues, and the size of the involved chromosome segments. It is generally believed that non-mosaic forms are more severe in phenotype than mosaic forms, leading to premature death or developmental delay [9, 14]. This study reports the prenatal diagnosis and long-term follow-up of a T9p mosaic child without obvious abnormal clinical manifestations. Case report A 34-year-old woman, who claimed no family history of genetic abnormalities and previously delivered one healthy boy, was referred to Shaoxing Maternity and Child Health Care Hospital. She underwent selective amniocentesis at 19 weeks of pregnancy due to non-invasive prenatal testing indicating an increase in the whole of chromosome 9. The karyotype of cultured amniocytes was 47,XY,+i(9)(p10)[3]/46,XY[97] and CNV-seq analysis of DNA extracted from uncultured amniocytes showed a result consistent with the copy number gain of chromosome 9p estimated at 6% mosaicism described using the International System for Human Cytogenomic Nomenclature (ISCN 2020) as seq[GRC37] 9p24.3q21.11(473858_71041685)x2 ~ 4. After genetic counseling, the pregnant woman and her family requested to continue the pregnancy. At 25 weeks of gestation, ultrasound examination revealed hyperechoic foci in the papillary muscles and chordae tendineae of the fetal cardiac left ventricle. The width of the posterior horn of the lateral ventricle measured approximately 10 mm at 38 weeks of gestation. At 39 weeks of gestation, a phenotypically normal 3.9 kg male baby was delivered. When followed-up at age of 3, the boy was phenotypically normal, and the peripheral blood had a karyotype of 47,XY,+i(9)(p10)[10]/46,XY[90], CNV-seq analysis of DNA extracted from uncultured peripheral blood cells showed a result consistent with the copy number gain of chromosome 9p estimated at a level of 53% mosaicism described using the International System for Human Cytogenomic Nomenclature (ISCN 2020) as seq[GRC37] 9p24.3p13.1(10001_39168998)x2 ~ 4. Interphase fluorescence in situ hybridization (FISH) on uncultured oral mucosal cells and urinary sediment cells showed 11.2% (12/95 cells) and 12.7% (7/48 cells) mosaicism for T9p respectively. Materials and methods Karyotype analysis Amniotic fluid (AF) and peripheral blood (PB) cells were cultured, harvested, and stained with Giemsa according to standard laboratory protocol. Generally, 20 metaphases were counted, and 6 metaphases were analyzed. The chromosome karyotypes were described per ISCN 2020 standards. In this case, we scaled up to 100-cell metaphase chromosome karyotypes. C-banding was performed according to standard laboratory protocol. Copy number variation sequencing (CNV-seq) Genomic DNA was extracted from uncultured AF (8 ml) and PB (2 ml) using a commercial DNA extraction kit (BGI, Shenzhen). Low-coverage whole-genome sequencing was performed using the BGI sequencing platform. Library preparation followed standard protocols for CNV detection, aiming for an average sequencing depth of approximately 0.1x to 0.2x across the genome. Raw sequencing reads were aligned to the human reference genome (GRCh37/hg19) using Burrows-Wheeler Aligner (BWA). Copy number analysis and mosaic level estimation were performed using BGI’s bioinformatics pipeline, which includes the Zebracall algorithm for CNV calling and the PSCC (Population-based Segmentation and CNV Calling) software for data segmentation and normalization. The mosaic proportion was calculated based on the deviation of read depth in the target region from the expected diploid baseline. Identified CNVs were interpreted with reference to the DECIPHER (https://www.deciphergenomics.org), ClinGen (https://www.clinicalgenome.org), OMIM (https://www.omim.org) and other databases, and search the literature database such as the United States Medical Abstracts Database (https://pubmed.ncbi.nlm.nih.gov/). Variant classification was conducted in accordance with the guidelines of the American College of Medical Genetics and Genomics (ACMG), categorizing findings as pathogenic, likely pathogenic, variant of uncertain significance (VUS), likely benign, or benign. Fluorescence in situ hybridization analysis (FISH) The oral mucosal samples and urinary sediment cell samples from the child were sent to the Reproductive and Stem Cell Institute of Central South University for FISH analysis. The specimens. were hybridized with a Tel 9p (green)/Tel 9q (red) subtelomeric probe (Vysis probes, Abbott, Illinois, USA) combination and examined under a fluorescence microscope for chromosomal analysis according to standard laboratory protocol. Results Karyotype analysis AF karyotype was 47,XY,+i(9)(p10)[3]/46,XY[97]. At 3 years old, PB karyotype was 47,XY,+i(9)(p10)[10]/46,XY[90]. The peripheral blood chromosome karyotypes of both parents were normal. C-banding shows one dark band in the middle of the chromosome 9, indicating the presence of a single heterochromatic region in the i(9p) chromosome. (Fig. 1). The G-banding karyotype results from the case with cultured amniotic fluid cells (a) and peripheral blood cells (b). The C-banding karyotype results from the case with peripheral blood cells (c). Arrows indicate T9p CNV-seq results AF: seq[GRCh37] 9p24.3q21.11(473858_71041685)x2 ~ 4, classified as pathogenic. (Fig. 2). CNV-seq on DNA prepared from uncultured amniocytes (a) and peripheral blood cells (b). Results for chromosome 9 showing gain of the entire p arm PB: seq[GRCh37] 9p24.3p13.1(10001_39168998)x2 ~ 4, classified as pathogenic. (Fig. 2). CNV-seq of peripheral blood revealed a 39.16 Mb copy number gain in the p24.3p13.1 region with a mosaic ratio of 53%, which differed in 9p segment size and location from the amniotic fluid CNV-seq results. Such discrepancies might be attributed to the segmentation algorithm’s extension of segment calls through the pericentromeric region on 9p, the centromere of chromosome 9, and the heterochromatic 9qh region. This is primarily because shallow sequencing lacks the resolution to accurately align reads across these complex, repetitive genomic regions. FISH results T9p mosaicism was 11.2% (12/95 cells) in oral mucosal cells and 12.7% (7/48 cells) in urinary sediment cells. (Fig. 3). Customized special 9p probe, green represents the 9p signal, and red represents the 9q signal. (a) normal FISH of oral mucosal cells. (b) abnormal T9p FISH of oral mucosal cells. (c) normal FISH of urinary sediment cells. (d) abnormal T9p FISH of urinary sediment cells Clinical follow-up Prenatal ultrasound showed cardiac left ventricular echogenic focus (24 weeks) and lateral ventricle width of 10 mm (38 weeks). After multiple genetic counseling, a phenotypically normal 3.9 kg (3.3 ± 0.4 kg) male baby was delivered at 39 weeks of gestation. After regular follow-up, the growth and development indicators of this child, such as height, weight, gross motor skills, and fine motor skills, were normal based on the World Health Organization (WHO) Child Growth Standards (M ± SD). Now the boy is 3 years old, with a height of 97 cm (96.1 ± 3.7 cm), a weight of 14 kg (14.3 ± 2.6 kg), and a head circumference of 50 cm (49.5 ± 1.5 cm). We utilize the Developmental Screening Test for Children under six (DST) to assess the cognitive development of children aged 0–6, and the tests showed no obvious clinical manifestations of abnormality in intelligence, motor, language development and social adaptation. Discussion The clinical manifestations of mosaic and non-mosaic T9p syndrome exhibit remarkable variability, primarily including intellectual disability and developmental delay in 73% cases, growth retardation (39%), intrauterine growth restriction (28%), skeletal abnormalities (55%), genitourinary anomalies (43%), ocular abnormalities (42%), microcephaly (20%), auricular anomalies (69%), hypertelorism (46%), micrognathia (45%), and cleft lip/palate (32%) [4]. Additional reported features encompass Dandy-Walker malformation, congenital heart disease, joint dislocations, and digital hypoplasia [10]; [2, 5]. Prenatal diagnosis of T9p remains exceptionally rare, with an estimated frequency of 0.002% in amniocentesis [5]. Our institutional data from 27,622 amniotic fluid/cord blood karyotype analyses (2004–2025) identified only this one confirmed case. Studies have shown that tissue-specific mosaicism exists in T9p, with approximately 30% of T9p cases presenting mosaicism, characterized by a low proportion in fibroblasts or buccal mucosa and a high proportion of i(9p) in lymphocytes [11]. The underlying causes of phenotypic heterogeneity observed in T9p mosaic cases remain unclear, with potential explanations including the size, location, and extent of mosaicism for the triplicated region of i(9p), as well as the timing of the formation of the i(9p) and tissue distribution [10]. However, accurate prediction of fetal clinical phenotype prenatally is not feasible. Although 9 cases of T9p mosaicism with no obvious abnormal clinical phenotypes have been reported, Zhang et al., [17] described the first case with phenotypic documentation from early pregnancy to postpartum. Chen et al., (2024b) suggested that T9p mosaicism without fetal abnormalities detected during amniocentesis may represent a transient benign condition with a potentially favorable fetal prognosis [3]. Nevertheless, prenatal genetic counseling for T9p is extremely challenging, with 2 reported cases of prenatal diagnosis resulting in pregnancy termination [15, 16]. In this case report, prenatal non-invasive testing indicated an increased number of chromosome 9. Chromosomal karyotype analysis of cultured amniotic fluid cells, with an increased count of karyotypes, revealed a T9p mosaicism of 3%, while CNV-seq of uncultured amniotic fluid cells showed a copy number gain in the 9p24.3q21.11 with a mosaicism of 6%. Due to mosaicism, CNV-seq only indicated an increase in copy number gain in this region but could not determine the location in the genome and the type of structural variant of the additional segment. Combining chromosomal karyotype and CNV-seq results, low-level mosaic T9p was confirmed in the amniotic fluid of the fetus. The most common features of prenatally detected T9p include intrauterine growth retardation, central nervous system abnormalities, skeletal abnormalities, genitourinary and renal abnormalities, and cardiac defects [14]. However, the fetus had a normal nuchal translucency (NT) measurement of 1.4 mm at 13 weeks of gestation, and no significant abnormalities were found on prenatal ultrasound. Based on ultrasound imaging findings, genetic counselors informed the parents that typical T9p syndrome presents with severe intellectual disability and developmental delay, but the clinical phenotype of mosaic T9p is closely related to the tissue distribution of abnormal cells, which cannot be accurately determined by prenatal diagnosis. After genetic counseling, the parents decided to continue the pregnancy, and genetic counselors recommended intensified prenatal check-ups, monitoring of fetal growth and development, and secondary prenatal diagnosis if necessary. After five detailed ultrasonographic examinations no significant structural abnormalities were observed except for a isolated left cardiac ventricular echogenic focus detected by B-ultrasound (not clinically significant) and cardiac ultrasound at 24 weeks, and a posterior horn width of the lateral ventricle of approximately 10 mm (the critical value) on B-ultrasound at 38 weeks throughout the pregnancy. Regular follow-up showed that growth indicators such as height, weight, gross motor, and fine motor skills were normal. Currently, the child is 3 years old, with the average height and weight, showing no obvious abnormal clinical manifestations in psychomotor or language development. At 3 years of age, re-examination of chromosomal karyotype in cultured peripheral blood cells showed a T9p mosaicism of 10% (10/100), which was different from the mosaicism at 3% in amniotic fluid. The tissue limited mosaicism might also reflect cell culture bias and growth kinetics between fibroblast and blood lymphocyte cultures. And the difference between 3 and 10% is not a dramatic change in proportion and could still be related to sampling. The CNV-seq was reported indicating mosaicism for the copy number gain, however G-banding karyotype revealed the 9p copy number gain reflected T9p mosaicism. This is the limitation of the CNV-seq assay to accurately describe the location and type of structural rearrangement. Subsequent interphase FISH analysis of oral mucosa and urinary sediment cells reported T9p mosaicism of 11.2% (12/95 cells) and 12.7% (7/48 cells) respectively. Based on the combined results of peripheral blood chromosomal karyotype analysis, peripheral blood CNV-seq, and interphase FISH of oral mucosa and urinary sediment cells, the child was confirmed to have low-level mosaic T9p. Nevertheless, the cumulative evidence failed to demonstrate that this chromosomal fragment extended across the centromere of chromosome 9 to the q arm of chromosome 9. Based on previous reports, among the 9 cases of mosaic T9p that were incidentally discovered without obvious abnormal clinical phenotypes such as any anatomical or intellectual issues, there were manifestations such as skin lesions, oligoasthenozoospermia, and premature ovarian failure [17]. We estimated that under these circumstances, aberrant cell lines may not exist in the brain and other vital organs. The boy in this case is only 3 years old and has no abnormal clinical manifestations mentioned above. We will continue to follow up and monitor his growth, development and other abnormal clinical phenotypes. Conclusion In summary, this article applied chromosome karyotyping analysis, CNV-seq, and FISH detection techniques to jointly diagnose a T9p mosaic case with no obvious abnormal clinical manifestations recorded from early pregnancy to 3 years postpartum. It is crucial to document cases of mosaic T9p without abnormal phenotypes, as this information is valuable for genetic counseling and for parents considering keeping fetus with this condition. This enriches the clinical spectrum of T9p mosaicism and provides a basis for prenatal diagnosis and genetic counseling of children with this type of chromosome aberration. Acknowledgements We extend our sincere gratitude to the families and patients who participated in this study. Author contributions Lifang Zhang: Performed experiments, collected and analyzed data, and drafted the manuscript.Feiyan Qian: Conducted experimental procedures.Weiping Chen: Performed experimental operations.Jiaming Fan: Provided technical support.Yan Zeng: Contributed to sample preparation and data collection.Tingting Luo: Assisted in laboratory maintenance and documentation.Ming Che: Supported data management.Bin Yu:Reviewed the manuscript.Tao Zhang: Analyzed and interpreted data, critically reviewed the manuscript, and supervised the study. Funding The authors declare that financial support was received for the research and/or publication of this article. This work was supported by: 1. Zhejiang Provincial Natural Science Foundation of China (LTGY23H040005); 2. Shaoxing Municipal Health Commission Science and Technology Program (2023SSY005); 3. Zhejiang University Shaoxing Research Institute - Shaoxing Maternal and Child Health Care Hospital Joint Research Grant for Life and Health (2025SMJK003). Data availability No datasets were generated or analysed during the current study. Declarations Ethics approval The studies involving humans were approved by Shaoxing Maternity and Child Health Care Hospital. The studies were conducted in accordance with the local legislation and institutional requirements. Written informed consent for participation in this study was provided by the participants’ legal guardians/next of kin. Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article. Competing interests The authors declare no competing interests. Generative AI statement The author(s) declare that no Generative AI was used in the creation of this manuscript. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Data Availability Statement No datasets were generated or analysed during the current study.